Science Without Boundaries: Early-Stage Lung Cancer Highlights from WCLC 2026

The 2026 World Conference on Lung Cancer (WCLC) brought the global thoracic oncology community to Seoul, South Korea from September 12–15. This year's theme, “Science Without Boundaries: Uniting the World Against Thoracic Cancer,” was particularly fitting for early-stage lung cancer, where treatment before and after surgery is rapidly evolving through multinational studies. Here are the conference highlights, organized by immunotherapy, targeted therapy, surgery, and supportive care. Immunotherapy Before and After Surgery Does perioperative atezolizumab improve survival? Not quite The phase 3

Science Without Boundaries: Metastatic NSCLC Highlights from WCLC 2026

The International Association for the Study of Lung Cancer (IASLC) 2026 World Conference on Lung Cancer (WCLC) brought the global thoracic oncology community to Seoul, Republic of Korea, from September 12–15. This year's theme, "Science Without Boundaries: Uniting the World Against Thoracic Cancer," was truly fitting for a meeting where research from Asia, Europe, and the Americas shaped the conversation around approaches to treating metastatic/advanced non-small cell lung cancer (NSCLC). Longer survival follow-up, new first-line options for rare mutations, and a growing focus on healthcare

EGFR in 2026: What’s New and What’s Next

LUNGevity offers a variety of virtual support groups called ‘meetups’ where survivors and caregivers impacted by lung cancer connect with others who understand the patient experience. Once a month, we invite an expert to share information on a topic related to life with lung cancer, engage with attendees, and answer questions in real time. Visit the LUNGevity Calendar to see upcoming events like this one. In September, we were joined by Dr. Benjamin Levy, MD, thoracic medical oncologist and clinical director of medical oncology for the Johns Hopkins Sidney Kimmel Cancer Center at Sibley

Real Progress and Real Gaps: Highlights of the 2026 AACR Disparities Report

I have spent my career focused on the intersection between cancer research and public health. Since joining LUNGevity over a decade ago, it has been nothing short of a privilege to witness how research has changed how we diagnose and treat lung cancer. We have seen unimaginable improvements in the field. However, this scientific progress seems to have outpaced our ability to effectively deliver these benefits to all patients. Key questions remain: Is every person at an increased risk of developing lung cancer getting screened? Is every person diagnosed with lung cancer receiving the best

Top Lung Cancer Research Highlights from ASCO 2026

Each year, the American Society of Clinical Oncology (ASCO) Annual Meeting brings together the world’s largest gathering of the oncology community. Approximately 40,000 researchers, physicians, nurses, advocates, biotech and pharmaceutical professionals, and others, meet annually to discuss research that shapes how cancer is diagnosed, treated, and managed. The 2026 meeting took place May 29 - June 2 in Chicago and included important advances in lung cancer treatment. We saw awe-inspiring long-term results from a targeted therapy, new approaches for patients with specific biomarkers

Precision, Partnership, Purpose: Lung Cancer Highlights from AACR 2026

The American Association for Cancer Research (AACR) Annual Meeting brought together thousands of cancer researchers, clinicians, advocates, and patients in San Diego from April 17–22. This year's theme—“Precision, Partnership, Purpose: Advancing Cancer Science to Save Lives Globally”—set a powerful tone for a meeting that showcased advances across the lung cancer landscape. One message was loud and clear. Science is accelerating, and we are reimagining how healthcare is delivered. From next-generation targeted therapies to AI-powered diagnostics, AACR 2026 offered a snapshot of both the

Watch HOPE Summit 2026 Videos

HOPE Summit 2026 was filled with old friends reuniting, new friends being made, and of course, plenty of inspirational and informative sessions designed to help people live well with lung cancer. For the second year in a row, select sessions were recorded so those who could not attend are still able to access the valuable information shared. HOPE Summit 2026 Recorded Sessions Keynote: Wagons Roll with Dr. Ross Camidge Back in the Saddle: Reclaiming Strength and Living Well Charting New Territory with Palliative Care Partners Community Connections Across the Horizon Experts Around the Campfire

Clinical Trial Access Isn’t Expanding. It’s Concentrating.

Clinical trials show us whether a new treatment is safe and effective. They are also an important way for patients to access cutting-edge care. For trials to truly serve the lung cancer community, the people who enroll in the trials need to represent the populations who are diagnosed in everyday life. Recognizing these needs, federal agencies like the United States Food and Drug Administration (FDA) have been encouraging clinical trials to offer more locations across the US. The Plan The intention is that a broader footprint of clinical trials can reduce barriers for patients and help studies

Meet The “Mini-Organs” of Lung Cancer Research

Though many of us would like to deny it, our neighbors affect us. Their loud music disturbs our sleep. The scent of their dinner wafts through an open window. The sight of their new puppy brings a smile. We interact with our environment every moment of the day. And so do lung cancer cells. A Brief History Traditionally, we have studied tumor cells in isolation. We often study single cells in a petri dish, or under a microscope, to understand how they work. This has been very important and effective. Studying individual cells continues in labs around the world and it leads us to understand many

Three Moments That Defined the 2026 Targeted Therapies of Lung Cancer Conference

The 2026 Targeted Therapies of Lung Cancer Meeting brought together leading clinicians, researchers, and patient advocates to discuss the latest advances shaping the future of lung cancer care. Hosted by the International Association for the Study of Lung Cancer, this annual gathering was held in Huntington Beach, California from Feb. 18-21, 2026. It has become known as one of the key meetings for participants to discuss the latest breakthroughs and challenges in lung cancer. This year’s meeting featured many meaningful sessions, but three stood out for their scientific insights, human